JP Morgan Chase’s HOOKIPA Pharma HOOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-815
| Closed | -$1.02K | – | 7549 |
|
|
2025
Q2 | $1.02K | Sell |
815
-111
| -12% | -$137 | ﹤0.01% | 6617 |
|
|
2025
Q1 | $1K | Buy |
926
+38
| +4% | +$63 | ﹤0.01% | 6630 |
|
|
2024
Q4 | $1.78K | Hold |
888
| – | – | ﹤0.01% | 6663 |
|
|
2024
Q3 | $3.82K | Buy |
888
+887
| +88,700% | +$4.68K | ﹤0.01% | 6533 |
|
|
2024
Q2 | $8 | Hold |
1
| – | – | ﹤0.01% | 7222 |
|
|
2024
Q1 | $10 | Hold |
1
| – | – | ﹤0.01% | 7229 |
|
|
2023
Q4 | $11 | Hold |
1
| – | – | ﹤0.01% | 7412 |
|
|
2023
Q3 | $9 | Hold |
1
| – | – | ﹤0.01% | 7306 |
|
|
2023
Q2 | $12 | Hold |
1
| – | – | ﹤0.01% | 6811 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6941 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6741 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6622 |
|
|
2022
Q2 | $0 | Sell |
1
-901
| -100% | -$14.9K | ﹤0.01% | 6643 |
|
|
2022
Q1 | $21K | Sell |
902
-8,327
| -90% | -$149K | ﹤0.01% | 6061 |
|
|
2021
Q4 | $215K | Buy |
9,229
+1,940
| +27% | +$78K | ﹤0.01% | 5304 |
|
|
2021
Q3 | $429K | Buy |
7,289
+6,548
| +884% | +$475K | ﹤0.01% | 4819 |
|
|
2021
Q2 | $68K | Sell |
741
-3,004
| -80% | -$401K | ﹤0.01% | 5655 |
|
|
2021
Q1 | $504K | Buy |
3,745
+352
| +10% | +$42.5K | ﹤0.01% | 4669 |
|
|
2020
Q4 | $376K | Buy |
3,393
+2,448
| +259% | +$264K | ﹤0.01% | 4531 |
|
|
2020
Q3 | $92K | Sell |
945
-72
| -7% | -$7.34K | ﹤0.01% | 4730 |
|
|
2020
Q2 | $118K | Sell |
1,017
-612
| -38% | -$59.7K | ﹤0.01% | 4494 |
|
|
2020
Q1 | $134K | Buy |
1,629
+315
| +24% | +$34.5K | ﹤0.01% | 4430 |
|
|
2019
Q4 | $161K | Buy |
1,314
+1,245
| +1,804% | +$106K | ﹤0.01% | 4751 |
|
|
2019
Q3 | $5K | Buy |
69
+12
| +21% | +$885 | ﹤0.01% | 5566 |
|
|
2019
Q2 | $4K | Buy |
+57
| New | +$6.05K | ﹤0.01% | 5644 |
|
Other funds holding HOOK
KCM
JC
XT
JP Morgan Chase's HOOK Position: Q3 2025 in Review
JP Morgan Chase sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 815 shares — an estimated $1.02K sold.
JP Morgan Chase first reported a position in HOOK in Q2 2019 and held it in 25 quarters. The position peaked at $504K in Q1 2021. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.
- JP Morgan Chase reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
- JP Morgan Chase sold 815 HOOKIPA Pharma shares in Q3 2025, an estimated $1.02K.
- JP Morgan Chase first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 25 quarters.
- JP Morgan Chase's HOOKIPA Pharma position peaked at $504K in Q1 2021.
- 6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.
Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.